Inspire Veterinary Partners, Inc. (IVP)
NASDAQ: IVP · Real-Time Price · USD
0.103
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
0.0734
-0.0291 (-28.39%)
After-hours: Dec 5, 2025, 7:59 PM EST

Company Description

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States.

The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds, including equine care.

It also provides surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services.

In addition, the company offers hospitals which provides preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services.

Inspire Veterinary Partners, Inc. was incorporated in 2020 and is based in Virginia Beach, Virginia.

Inspire Veterinary Partners, Inc.
Inspire Veterinary Partners logo
Country United States
Founded 2020
IPO Date Aug 30, 2023
Industry Personal Services
Sector Consumer Discretionary
Employees 113
CEO Kimball Carr

Contact Details

Address:
780 Lynnhaven Parkway, Suite 400
Virginia Beach, Virginia 23452
United States
Phone 757 734 5464
Website inspirevet.com

Stock Details

Ticker Symbol IVP
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
IPO Price $4.00
CIK Code 0001939365
CUSIP Number 45784E304
ISIN Number US45784E3045
Employer ID 85-4359258
SIC Code 0700

Key Executives

Name Position
Kimball Carr Chairman, Chief Executive Officer and President
Richard Paul Frank Chief Financial Officer
Laura Johnson Vice President of Operations
Lynley Kees Chief People Officer
Dr. Alexandra Quarti Vice President of Medical Operations
Morgan Wood Senior Manager of Human Resources and Administration
Debbe Bastian Financial Controller

Latest SEC Filings

Date Type Title
Dec 5, 2025 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Dec 5, 2025 8-K Current Report
Nov 24, 2025 8-K Current Report
Nov 17, 2025 8-K Current Report
Nov 14, 2025 SCHEDULE 13G/A Filing
Nov 12, 2025 10-Q Quarterly Report
Nov 10, 2025 8-K Current Report
Oct 24, 2025 ARS Filing
Oct 24, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Oct 24, 2025 DEF 14A Other definitive proxy statements